• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2013 年成人哮喘诊断和治疗的进展。

Advances in adult asthma diagnosis and treatment in 2013.

机构信息

Division of Pulmonary, Allergy, & Critical Care Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, Pa.

出版信息

J Allergy Clin Immunol. 2014 Jan;133(1):49-56. doi: 10.1016/j.jaci.2013.11.005.

DOI:10.1016/j.jaci.2013.11.005
PMID:24369799
Abstract

In 2013, several themes emerged: (1) a dedicated search for new therapies using new mechanisms; (2) the importance of the plasticity of the immune system (eg, that molecules that mediate inflammation in one setting can promote its resolution and return to homeostasis in other circumstances); (3) the complex role of viruses in asthma exacerbations; (4) the similarities and differences among asthma, asthma in smokers, and chronic obstructive pulmonary disease; and (5) the importance of understanding asthma phenotypes and their stability over time. Once new therapeutics pass the initial clinical trials, patient-oriented and real-world research will be needed.

摘要

2013 年,出现了几个主题:(1)专注于使用新机制寻找新疗法;(2)免疫系统可塑性的重要性(例如,在一种情况下介导炎症的分子可以促进其解决并在其他情况下恢复到体内平衡);(3)病毒在哮喘恶化中的复杂作用;(4)哮喘、吸烟者哮喘和慢性阻塞性肺疾病之间的相似性和差异;(5)了解哮喘表型及其随时间的稳定性的重要性。一旦新的疗法通过初步临床试验,就需要进行以患者为导向和真实世界的研究。

相似文献

1
Advances in adult asthma diagnosis and treatment in 2013.2013 年成人哮喘诊断和治疗的进展。
J Allergy Clin Immunol. 2014 Jan;133(1):49-56. doi: 10.1016/j.jaci.2013.11.005.
2
Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.从沙美特罗/氟替卡松转换为福莫特罗/布地奈德联合治疗可改善哮喘的外周气道/肺泡炎症。
Pulm Pharmacol Ther. 2014 Feb;27(1):52-6. doi: 10.1016/j.pupt.2013.04.001. Epub 2013 Apr 11.
3
Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids.最佳哮喘治疗的双重成分:联合使用长效β受体激动剂与吸入性糖皮质激素的科学及临床依据
J Am Osteopath Assoc. 2001 Sep;101(9):526-33.
4
Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and small airway impairment in patients who need to step-up from inhaled corticosteroid monotherapy.比较布地奈德/福莫特罗维持和缓解治疗与氟替卡松/沙美特罗固定剂量治疗对需要从吸入性皮质激素单药治疗升级的患者气道炎症和小气道损害的影响。
Pulm Pharmacol Ther. 2014 Apr;27(2):190-6. doi: 10.1016/j.pupt.2013.12.003. Epub 2014 Jan 2.
5
Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes.哮喘-慢性阻塞性肺疾病重叠综合征的治疗方法。
J Allergy Clin Immunol. 2015 Sep;136(3):531-45. doi: 10.1016/j.jaci.2015.05.052.
6
Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma.慢性阻塞性肺疾病和哮喘急性加重的当前及未来药物治疗
Proc Am Thorac Soc. 2004;1(2):136-42. doi: 10.1513/pats.2306035.
7
[Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].[布地奈德/福莫特罗维持与缓解治疗。一种针对成年哮喘患者的新治疗方法]
Med Klin (Munich). 2008 May 15;103(5):299-310. doi: 10.1007/s00063-008-1050-y.
8
[Corticosteroid treatment in airways narrowing].[气道狭窄的皮质类固醇治疗]
Pneumonol Alergol Pol. 2008;76(2):96-100.
9
Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.皮质类固醇与肾上腺素能受体激动剂:慢性气道疾病联合治疗的优势
Eur J Pharmacol. 2006 Mar 8;533(1-3):28-35. doi: 10.1016/j.ejphar.2005.12.049. Epub 2006 Feb 7.
10
Exhaled nitric oxide in childhood allergic asthma management: a randomised controlled trial.儿童过敏性哮喘管理中的呼出一氧化氮:一项随机对照试验。
Pediatr Pulmonol. 2014 Jul;49(7):624-31. doi: 10.1002/ppul.22873. Epub 2013 Sep 4.

引用本文的文献

1
Abnormal microarchitecture and stiffness in postmenopausal women using chronic inhaled glucocorticoids.绝经后女性长期吸入糖皮质激素导致的微观结构异常和硬度增加。
Osteoporos Int. 2018 Sep;29(9):2121-2127. doi: 10.1007/s00198-018-4591-9. Epub 2018 Jun 11.
2
Genetic variants and risk of asthma in an American Indian population.美洲印第安人群中的基因变异与哮喘风险
Ann Allergy Asthma Immunol. 2017 Jul;119(1):31-36.e1. doi: 10.1016/j.anai.2017.05.015.
3
Generation and characterization of an antagonistic monoclonal antibody against an extracellular domain of mouse DP2 (CRTH2/GPR44) receptors for prostaglandin D2.
针对前列腺素D2的小鼠DP2(CRTH2/GPR44)受体细胞外结构域的拮抗性单克隆抗体的产生与鉴定
PLoS One. 2017 Apr 10;12(4):e0175452. doi: 10.1371/journal.pone.0175452. eCollection 2017.
4
IL-4 Haploinsufficiency Specifically Impairs IgE Responses against Allergens in Mice.白细胞介素-4单倍体不足特异性损害小鼠针对过敏原的IgE反应。
J Immunol. 2017 Mar 1;198(5):1815-1822. doi: 10.4049/jimmunol.1601434. Epub 2017 Jan 23.
5
Humoral immune factors and asthma among American Indian children: a case-control study.美国印第安儿童的体液免疫因素与哮喘:一项病例对照研究。
BMC Pulm Med. 2016 Jun 13;16(1):93. doi: 10.1186/s12890-016-0257-6.
6
Deciphering Asthma Biomarkers with Protein Profiling Technology.利用蛋白质分析技术解读哮喘生物标志物
Int J Inflam. 2015;2015:630637. doi: 10.1155/2015/630637. Epub 2015 Aug 6.
7
The transcription factor PU.1 promotes alternative macrophage polarization and asthmatic airway inflammation.转录因子PU.1促进替代性巨噬细胞极化和哮喘气道炎症。
J Mol Cell Biol. 2015 Dec;7(6):557-67. doi: 10.1093/jmcb/mjv042. Epub 2015 Jun 22.
8
AcCystatin, an immunoregulatory molecule from Angiostrongylus cantonensis, ameliorates the asthmatic response in an aluminium hydroxide/ovalbumin-induced rat model of asthma.来自广州管圆线虫的免疫调节分子AcCystatin可改善氢氧化铝/卵清蛋白诱导的大鼠哮喘模型中的哮喘反应。
Parasitol Res. 2015 Feb;114(2):613-24. doi: 10.1007/s00436-014-4223-z. Epub 2014 Nov 18.